Carcinogen in Zantac Leads to Another Shipment Halt, Recall
Workers pour in raw material to produce medicine capsules at Dr Reddy’s plant in Bachupally, Andra Pradesh. (Photographer: Amit Bhargava/Bloomberg News)

Carcinogen in Zantac Leads to Another Shipment Halt, Recall

Bookmark
(Bloomberg) -- A global effort to remove gastrointestinal medication tainted with a potential carcinogen from the market gained momentum, as one of India’s largest generic drugmakers halted shipmen...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.